Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
P3 Health Partners (PIII)
NASDAQ:PIII
PIII Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.17 - $1.20
Previous CloseN/A
Volume132.39K
Average Volume (3M)4.29M
Market Cap
$78.26M
Enterprise Value$283.52M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta2.29
Next Earnings
Mar 28, 2025EPS Estimate
-0.08Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.84
Shares Outstanding162,863,300
10 Day Avg. Volume1,802,649
30 Day Avg. Volume4,291,160
Standard Deviation0.39
R-Squared0.01
Alpha-0.05
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.05
Price to Cash Flow (P/CF)-0.90
P/FCF Ratio0.00
Enterprise Value/Market Cap3.62
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit8.96
Enterprise Value/Ebitda-1.98
Forecast
1Y Price Target
$30.50Price Target Upside14423.81% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
---
P3 Health Partners News
PremiumCompany Announcements
P3 Health Partners Announces 2025 Financial Guidance
PremiumCompany Announcements
P3 Health Partners Secures $25M Financing Agreement
PremiumCompany Announcements
P3 Health Partners Reports Increased Revenue Amidst Challenges
---
Bulls Say, Bears Say
Bulls Say
Bears Say
EarningsThe company posted an Adjusted EBITDA of ($71 million), which is significantly below the estimated +$3.9 million and consensus +$9.5 million.
Financial PerformanceThe 2024 EBITDA estimates have been lowered from a previous ($22 million) to ($131 million).
Future PerformancePIII withdrew 2024E guidance for all metrics, indicating low visibility and uncertainty in its future performance.
---
Ownership Overview
60.18% Insiders
1.83% Mutual Funds
8.52% Other Institutional Investors
28.30% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
PIII FAQ
What was P3 Health Partners’s price range in the past 12 months?
P3 Health Partners lowest stock price was $0.17 and its highest was $1.20 in the past 12 months.
What is P3 Health Partners’s market cap?
P3 Health Partners’s market cap is $78.26M.
When is P3 Health Partners’s upcoming earnings report date?
P3 Health Partners’s upcoming earnings report date is Mar 28, 2025 which is in 34 days.
How were P3 Health Partners’s earnings last quarter?
P3 Health Partners released its earnings results on Nov 12, 2024. The company reported -$0.31 earnings per share for the quarter, missing the consensus estimate of -$0.037 by -$0.273.
Is P3 Health Partners overvalued?
According to Wall Street analysts P3 Health Partners’s price is currently Undervalued.
Does P3 Health Partners pay dividends?
P3 Health Partners does not currently pay dividends.
What is P3 Health Partners’s EPS estimate?
P3 Health Partners’s EPS estimate is -0.08.
How many shares outstanding does P3 Health Partners have?
P3 Health Partners has 162,863,300 shares outstanding.
What happened to P3 Health Partners’s price movement after its last earnings report?
P3 Health Partners reported an EPS of -$0.31 in its last earnings report, missing expectations of -$0.037. Following the earnings report the stock price went down -35.897%.
Which hedge fund is a major shareholder of P3 Health Partners?
Currently, no hedge funds are holding shares in PIII
---
P3 Health Partners Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$30.50 (14423.81% Upside)
$30.50 (14423.81% Upside)
Blogger Sentiment
Bullish
PIII Sentiment 100%
Sector Average 70%
Sector Average 70%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-79.23%
12-Months-Change
Fundamentals
Return on Equity
-66.59%
Trailing 12-Months
Asset Growth
-7.09%
Trailing 12-Months
Company Description
P3 Health Partners
Foresight Acquisition Corp is a blank check company.
---
PIII Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted significant growth in revenue and strategic initiatives to improve profitability. However, the company faced challenges with EBITDA loss and increased medical expenses, leading to cash flow concerns and market exits. The sentiment is cautiously optimistic but tempered by financial and operational hurdles.Read More>---
PIII Stock 12 Month Forecast
Average Price Target
$30.50
▲(14423.81% Upside)
Technical Analysis
Teladoc
―
Hims & Hers Health
―
American Well
―
Clover Health Investments
―
Oscar Health
―
Best Analysts Covering PIII
1 Year
1 Year Success Rate
0/8 ratings generated profit
1 Year Average Return
-56.29%
reiterated a buy rating 10 days ago
Copying Brooks O'Neil's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -56.29% per trade.
---